Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $7.2M $3.0M $3.7M $8.5M $6.3M $1.7M $1.9M
Accounts Receivable — — — $298.0K $139.1K $141.7K $1.2K
Inventory — — $0 $9.3K $0 $0 —
Total Current Assets $7.9M $3.3M $4.3M $9.3M $6.8M $2.0M $2.9M
Property, Plant & Equipment $11.5K $55.1K $171.6K $136.7K $163.1K $160.0K $80.5K
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) $234.0K $640.4K $1.7M $1.9M $4.4M $4.6M $40.8K
Total Assets $8.2M $4.1M $6.2M $11.8M $12.0M $6.8M $3.1M
Liabilities
Accounts Payable $334.9K $254.3K $814.4K $513.0K $248.1K $68.2K $64.8K
Total Current Liabilities $1.2M $1.0M $2.5M $2.3M $1.4M $1.7M $1.5M
Long-Term Debt — — — $49.2K $5.8K — —
Total Liabilities $1.2M $1.0M $2.5M $2.3M $1.4M $1.7M $1.5M
Stockholders' Equity
Retained Earnings $-65.4M $-57.3M $-50.9M $-35.2M $-20.5M $-9.7M $-4.7M
Total Stockholders' Equity $6.9M $3.1M $3.7M $9.5M $10.6M $5.2M $1.6M
← Newer Page 2 of 2 Older →